Schedule of basic and diluted earnings per share |
| | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | 2021 | | 2020 | | 2021 | | 2020 | | | | (in thousands) | | (in thousands) | Numerator: | | | | | | | | | | | | | Net (loss) / income attributable to ordinary shares | | $ | (36,531) | | $ | (53,775) | | $ | 321,381 | | $ | (124,325) | | | | (36,531) | | | (53,775) | | | 321,381 | | | (124,325) | Denominator: | | | | | | | | | | | | | Weighted-average number of ordinary shares outstanding - basic | | | 46,152,404 | | | 44,471,844 | | | 45,888,769 | | | 44,379,924 | Stock options under 2014 Plans and previous plan | | | — | | | — | | | 784,942 | | | — | Non-vested RSUs and PSUs | | | — | | | — | | | 105,870 | | | — | Employee share purchase plan | | | — | | | — | | | 1,382 | | | — | Weighted-average number of ordinary shares outstanding - diluted | | | 46,152,404 | | | 44,471,844 | | | 46,780,963 | | | 44,379,924 |
|
Schedule of potential dilutive common shares |
| | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | 2021 | | 2020 | | 2021 | | 2020 | | | | (in thousands) | | (in thousands) | Anti-dilutive ordinary share equivalents | | | | | | | | | | | | | Stock options under 2014 Plans and previous plan | | | 3,357,412 | | | 2,960,158 | | | 2,572,470 | | | 2,960,158 | Non-vested RSUs and PSUs | | | 841,480 | | | 672,805 | | | 735,610 | | | 672,805 | Employee share purchase plan | | | 1,219 | | | 1,997 | | | 1,219 | | | 1,997 | BMS warrants (derecognized as of December 1, 2020 - refer to Note 6, "Fair value measurement") | | | — | | | 8,071,000 | | | — | | | 8,071,000 | Total anti-dilutive ordinary share equivalents | | | 4,200,111 | | | 11,705,960 | | | 3,309,299 | | | 11,705,960 |
|